The Current Ratio as of December 2025 (TTM) for Chordate Medical Holding AB (publ) (CMH.ST) is 1.97

According to Chordate Medical Holding AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 1.97. This represents a change of -0.07% compared to the average of 1.97 of the last 4 quarters.

Chordate Medical Holding AB (publ) (CMH.ST) Historical Current Ratio (quarterly & annually)

How has CMH.ST Current Ratio performed in the past?

The mean historical Current Ratio of Chordate Medical Holding AB (publ) over the last ten years is 1.98. The current 1.97 Current Ratio has changed 9.87% with respect to the historical average. Over the past ten years (40 quarters), CMH.ST's Current Ratio was at its highest in in the December 2021 quarter at 6.16. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Chordate Medical Holding AB (publ) (CMH.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Chordate Medical Holding AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chordate Medical Holding AB (publ) (CMH.ST) Average Current Ratio

How has CMH.ST Current Ratio performed in the past?

The current Current Ratio of Chordate Medical Holding AB (publ) (CMH.ST) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Chordate Medical Holding AB (publ) (CMH.ST) Current Ratio vs. Peers

How is CMH.ST’s Current Ratio compared to its peers?

Chordate Medical Holding AB (publ)’s Current Ratio is greater than S2Medical AB (publ) (0.75), less than Stayble Therapeutics AB (publ) (7.18), greater than Quia Pharma AB (publ) (0.09), less than Spermosens AB (9.27), greater than Fluicell AB (publ) (1.83), greater than Gabather AB (publ) (0.77), less than LIDDS AB (publ) (4.04), less than Episurf Medical AB (publ) (2.75), less than ProstaLund AB (publ) (2.00), greater than Prostatype Genomics AB (publ) (1.95),

Build a custom stock screener for Chordate Medical Holding AB (publ) (CMH.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chordate Medical Holding AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chordate Medical Holding AB (publ) (CMH.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chordate Medical Holding AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.